# FDA Inspection 1201346 - Jerry R Mendell MD - March 24, 2023

Source: https://www.keypedia.com/records/fda_inspections/jerry-r-mendell-md/33e774d7-2d7d-47dd-8a89-b754187011cd
Source feed: FDA_Inspections

> FDA Inspection 1201346 for Jerry R Mendell MD on March 24, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1201346
- Company Name: Jerry R Mendell MD
- Inspection Date: 2023-03-24
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1132469 - 2020-10-28](https://www.keypedia.com/records/fda_inspections/jerry-r-mendell-md/d261ff10-cbff-4503-991e-608e4134ad1a)
- [FDA Inspection 1083158 - 2019-03-07](https://www.keypedia.com/records/fda_inspections/jerry-r-mendell-md/ce5d553b-f8a7-4c79-abcd-19681c3c6520)
- [FDA Inspection 982550 - 2016-08-19](https://www.keypedia.com/records/fda_inspections/jerry-r-mendell-md/0155c745-d45f-4dae-9730-ae7ccbf73fac)
- [FDA Inspection 858332 - 2013-12-05](https://www.keypedia.com/records/fda_inspections/jerry-r-mendell-md/139826ca-5f54-4ad5-8a9d-e93e6ed90819)

Company: https://www.keypedia.com/companies/jerry-r-mendell-md/c5d01790-d6c7-493b-90c5-9193920d8aa7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d